The leaflet provided by the manufacturer of Kalma is designed to help patients understand the risks and benefits of the medicine. It should not be used as a substitute for talking with a doctor, and is not intended to replace any advice given by a health care professional. Kalma is recommended for short-term treatment of anxiety and panic attacks. You should read it before taking the medicine and be sure to read it again.
The use of counterfeit medications should be avoided at all costs. While the name 'Kalma' is recognised in Australia, it is often a fake. The product's packaging and labeling are designed to mimic the prescription pharmaceutical brand. To prevent consuming the fake medicine, you should only purchase it from a registered Australian pharmacy. If you're concerned that you've taken too much, contact the Poisons Information Centre of NSW.
The drug may cause drowsiness, nervousness, and dizziness in some users. To avoid these effects, you should not drive or operate machinery while taking Kalma. Similarly, you should avoid drinking alcohol while taking this medicine, as it may affect your ability to function normally. Your doctor may want to reduce your dose slowly before stopping it entirely. If you've recently stopped taking Kalma, your doctor may want to consider switching to a different medication or reduce your dosage.
When to take Kalma, you should take it at the same time each day. It may help to take the tablet after a meal, as it will lessen the likelihood of sleepiness. Never take more Kalma than prescribed. Benzodiazepines are often prescribed for a short period of time, and may lead to dependency if not stopped properly. To avoid any unwanted side effects, talk to your doctor or pharmacist.
Beware of counterfeit medication. While Alprazolam is a genuine medication sold in the United States, counterfeits are available on the market. It's important to avoid purchasing fake Kalma, as these pills often contain undeclared ingredients. Among these are etizolam, promethazine, and amantadine. The Therapeutic Goods Administration has been working with the Australian Border Force to prevent future shipments of counterfeit alprazolam.